Top scientist defends decision to sell AstraZeneca vaccine at a profit

One of the scientists behind the Oxford/AstraZeneca Covid-19 vaccine has defended a decision to make profits on new supply deals, as the partnership announced that more than 2bn doses had been delivered. Sandy Douglas, a research group ...

from Google Alert - Business https://ift.tt/3ovH8dp
One of the scientists behind the Oxford/AstraZeneca Covid-19 vaccine has defended a decision to make profits on new supply deals, as the partnership announced that more than 2bn doses had been delivered. Sandy Douglas, a research group ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize